MedPath

To evaluate the efficacy of haritaki lepa in the management of acne post-inflammatory hyperpigmentatio

Phase 2
Conditions
Health Condition 1: L810- Postinflammatory hyperpigmentation
Registration Number
CTRI/2022/06/043361
Lead Sponsor
Sri Sri College of Ayurvedic Science and ResearchBangalore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

subjects diagnosed with acne post-inflammatory hyperpigmentation.

subjects of age group between 20-40years will be included irrespective of their gender, religion and socio-economic status.

subjects who are willing to participate in the study will be included

Exclusion Criteria

subjects with PIH due to mechanical trauma will be excluded.

subjects taking photosensitizing drug will be excluded.

subjects with melasma will be excluded.

subjects who have undergone chemical peeling of skin will be excluded.

subjects who have photosensitivity of skin due to systemic diseases, side effects of any cosmetic products will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of Haritaki Lepa in Acne <br/ ><br>Post inflammatory hyperpigmentationTimepoint: Post inflammatory hyperpigmentation severity scale <br/ ><br>assessment will be done- <br/ ><br>pre study assessment-0th day <br/ ><br>1st assessment - 7th day <br/ ><br>2nd assessment-14th day <br/ ><br>1st follow up -21st day
Secondary Outcome Measures
NameTimeMethod
To re-evaluate the effect of conventional topical cream (mederma) in Acne <br/ ><br>Post inflammatory hyperpigmentation. <br/ ><br>to compare the efficacy of haritaki lepa with conventional topical cream (mederma) in Acne <br/ ><br>Post inflammatory hyperpigmentation.Timepoint: Post inflammatory hyperpigmentation severity scale <br/ ><br>assessment will be done- <br/ ><br>pre study assessment-0th day <br/ ><br>1st assessment - 7th day <br/ ><br>2nd assessment-14th day <br/ ><br>1st follow up -21st day
© Copyright 2025. All Rights Reserved by MedPath